How many clinical trials are tracked of inotuzumab ozogamicin?

11 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

inotuzumab ozogamicin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of inotuzumab ozogamicin

11 trials tracked of inotuzumab ozogamicin: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 75 citations.

11Trials tracked

2Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 1 Phase 3 1 Phase 2 5 Phase 1 1 Other / NA 3

Phase 3 A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia Completed · 75 cited
Phase 4 A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Completed
Phase 2 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Completed
Phase 2 Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia Completed
Phase 2 Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML Completed
Phase 2 Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL) Completed

Show 5 more trials

Phase 2 CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies Completed
Phase 1 S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia Completed
N/A Besponsa Post Marketing Surveillance Study Completed
N/A A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment Completed
N/A InO - A Retrospective Study of UK Patients With Leukaemia Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.